Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8990
Corporate User License Price USD 375
Corporate User License Price INR 26970
Site License Price USD 250
Site License Price INR 17980
Request a Quote

Report Title

Achillion Pharmaceuticals Inc (ACHN) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Achillion Pharmaceuticals Inc (ACHN) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Achillion Pharmaceuticals Inc (ACHN) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Achillion Pharmaceuticals Inc (ACHN) - Financial and Strategic SWOT Analysis Review



Executive Summary

Achillion Pharmaceuticals Inc (ACHN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Achillion Pharmaceuticals Inc (Achillion) is a biopharmaceutical company which focuses on the discovery and development of small molecule therapeutic products for treatment of infectious diseases and immune system disorders. The company focuses at developing life-saving medicines to patients with rare diseases. It is developing oral antiviral therapy for chronic hepatitis C (HCV) and a platform of potent and specific complement inhibitors. Achillion intends to develop and commercialize factor D inhibitors for rare diseases including paroxysmal nocturnal hemoglobinuria (PNH), C3 Glomerulopathy (C3G), dry age-related macular degeneration (dry AMD) and chronic obstructive pulmonary disease (COPD). Achillion is headquartered in New Haven, Connecticut, the US.

Achillion Pharmaceuticals Inc Key Recent Developments

Sep 10,2018: Achillion Pharmaceuticals names Paul Firuta Chief Operating Officer

Aug 21,2018: Achillion Pharmaceuticals names Dr. Steven Zelenkofske as Chief Medical Officer

Aug 15,2018: Achillion Expands Management Team With Appointment of Anthony S. Gibney as Chief Business Officer

Aug 08,2018: Achillion reports second quarter 2018 financial results

May 02,2018: Achillion Reports First Quarter 2018 Financial Results and Management Transition

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Achillion Pharmaceuticals Inc-Key Facts 6

Achillion Pharmaceuticals Inc-Key Employees 7

Achillion Pharmaceuticals Inc-Key Employee Biographies 8

Achillion Pharmaceuticals Inc-Major Products and Services 9

Achillion Pharmaceuticals Inc-History 10

Achillion Pharmaceuticals Inc-Company Statement 12

Achillion Pharmaceuticals Inc-Locations And Subsidiaries 15

Head Office 15

Section 2-Company Analysis 16

Company Overview 16

Achillion Pharmaceuticals Inc-Business Description 17

R&D Overview 17

Achillion Pharmaceuticals Inc-Corporate Strategy 18

Achillion Pharmaceuticals Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

Achillion Pharmaceuticals Inc-Strengths 19

Achillion Pharmaceuticals Inc-Weaknesses 20

Achillion Pharmaceuticals Inc-Opportunities 21

Achillion Pharmaceuticals Inc-Threats 22

Achillion Pharmaceuticals Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Achillion Pharmaceuticals Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Aug 15, 2018: Achillion Expands Management Team With Appointment of Anthony S. Gibney as Chief Business Officer 33

Aug 08, 2018: Achillion reports second quarter 2018 financial results 34

May 02, 2018: Achillion Reports First Quarter 2018 Financial Results and Management Transition 36

Feb 28, 2018: Achillion Raises Awareness for C3 Glomerulopathy With Launch of WeC3G Initiative as Part of Rare Disease Day 2018 38

Feb 22, 2018: Achillion Announces Restructuring to Advance Corporate Strategy; Announces 2017 Fourth Quarter and Full Year Financial Results 39

Nov 01, 2017: Achillion Reports Third Quarter 2017 Financial Results and Provides Update on Clinical Programs 41

Sep 11, 2017: Achillion Announces Strengthening of Management Team 42

Aug 08, 2017: Achillion Reports Second Quarter 2017 Financial Results and Proof-of-Concept With a First-in-Class, Oral Factor D Inhibitor 43

Aug 03, 2017: Kidney Patients with C3G are Center of FDA Patient-Focused Meeting 46

Jul 10, 2017: Achillion Pharmaceutials Announces Key Promotion and Discovery Organization Change 48

Section 6-Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Achillion Pharmaceuticals Inc, Performance Chart (2013-2017) 27

Achillion Pharmaceuticals Inc, Ratio Charts 29

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

List of Tables

Achillion Pharmaceuticals Inc, Key Facts 6

Achillion Pharmaceuticals Inc, Key Employees 7

Achillion Pharmaceuticals Inc, Key Employee Biographies 8

Achillion Pharmaceuticals Inc, Major Products and Services 9

Achillion Pharmaceuticals Inc, History 10

Achillion Pharmaceuticals Inc, Key Competitors 23

Achillion Pharmaceuticals Inc, Ratios based on current share price 24

Achillion Pharmaceuticals Inc, Annual Ratios 25

Achillion Pharmaceuticals Inc, Annual Ratios (Cont...1) 26

Achillion Pharmaceuticals Inc, Interim Ratios 28

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Achillion Pharmaceuticals Inc, Recent Deals Summary 32

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Regulus Therapeutics Inc

Ra Pharmaceuticals, Inc.

Omeros Corporation

Novartis AG

Genentech, Inc.

ChemoCentryx, Inc

Amyndas Pharmaceuticals LLC

Amgen Inc.

Akari Therapeutics Plc

Achillion Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand